Lead optimization of novel p53-MDM2 interaction inhibitors possessing dihydroimidazothiazole scaffold
Miyazaki, M., Naito, H., Sugimoto, Y., Kawato, H., Okayama, T., Shimizu, H., Miyazaki, M., Kitagawa, M., Seki, T., Fukutake, S., Aonuma, M., Soga, T.(2013) Bioorg Med Chem Lett 23: 728-732
- PubMed: 23266121 
- DOI: 10.1016/j.bmcl.2012.11.091
- Primary Citation of Related Structures:  
3VZV - PubMed Abstract: 
With the aim of discovering potent inhibitors of the p53-MDM2 interaction and thus obtaining a potent anticancer drug, we have pursued synthesis and optimization of dihydroimidazothiazole derivatives, which have been discovered via scaffold hopping by mimicing the mode of interaction between MDM2 and Nutlins ...